Nillion (NIL/IDR) Price Today
Aura AI Summary
Key Stats
- Rp313,18MMarket Cap
- Rp207,81MVolume (24h)
- 487,4M NILCirculating Supply
- 48% Sell | 52% BuyTrading Activity
- 8 DaysTypical Hold Time
Nillion currently has a market capitalization of Rp313,18M and a 24-hour trading volume of Rp207,81M. Nillion has traded between an all-time low of Rp512.91 and an all-time high of Rp15,757.5. The circulating supply of Nillion stands at 487,4M NIL. Recent trading activity shows 48% Sell and 52% Buy, highlighting current market sentiment. On average, investors hold Nillion for approximately 8 Days.
About Nillion
Nillion is a private computation and storage network designed for artificial intelligence (AI) and data, known as the "blind computer." It uses Privacy-Enhancing Technologies (PETs) to enable secure data computation and storage while preserving privacy. The native utility token, NIL, is used for network fees, payments across the Coordination Layer and Petnet, staking for network security, and governance participation through the on-chain module.
Order Book
Shows real-time buy and sell orders, market depth, and short-selling activity to help investors gauge market sentiment.
Most Recent News
CLARITY Act may extend CFTC rules to crypto treasury firms, adding regulatory burdens amid a fragile market.
The CLARITY Act, poised for Senate approval, aims to clarify crypto regulation by placing Bitcoin and Ether under CFTC oversight. However, a little-noticed provision in the bill's conforming amendments could classify crypto treasury companies as comm...
Aave (AAVE) leads CoinDesk 20 gains with 5.9% rise as most crypto assets climb.
The CoinDesk 20 Index rose 0.5% to 1682.86, with 15 of 20 cryptocurrencies trading higher. Aave (AAVE) was the top performer, gaining 5.9%, followed by Internet Computer (ICP) up 2%. Meanwhile, Stellar (XLM) and Cardano (ADA) lagged, falling 1.4% and...
LAB token drops 13.41% amid concerns over token supply and ownership concentration.
LAB token fell 13.41% to $14.71 as concerns over token distribution and supply schedule resurfaced. Allegations of opaque OTC deals and concentrated ownership fueled worries about future unlocks adding selling pressure. Despite this, buyers defended ...
People also bought
Frequently Asked Questions
